Seaport Research Partners Anticipates TerrAscend's First Quarter Earnings

March 11, 2025 11:28 PM PDT | By Team Kalkine Media
 Seaport Research Partners Anticipates TerrAscend's First Quarter Earnings

Highlights

  • TerrAscend surpasses Q4 earnings expectations by reporting $0.01 EPS against a forecasted ($0.03).
  • Revenue for the quarter was $74.35 million, exceeding expectations of $72.37 million.
  • Current stock performance shows a decrease, opening at $0.44, with a market cap of $129.00 million.

TerrAscend Corp. (OTCMKTS:TSNDF) has demonstrated its capabilities in the rapidly evolving cannabis sector by exceeding analysts' expectations for the latest financial quarter. The company reported earnings of $0.01 per share for the recent quarter, distinctly surpassing the consensus estimated loss of ($0.03) per share. This outcome reflects a brilliant outperformance by $0.04, highlighting the company's efficiency in navigating market challenges.

Despite a negative return on equity of 31.48% and a negative net margin of 23.95%, TerrAscend's revenue generation appears robust. The reported quarterly revenue reached $74.35 million, eclipsing the forecast of $72.37 million. This favorable financial performance is indicative of strong market demand and strategic operations within the cannabis and wellness product segments.

Stock Market Analysis

Currently, TerrAscend's stock opened at $0.44, presenting a downward trend over 50 and 200-day moving average statistics. The company experiences a debt-to-equity ratio of 0.81, with current and quick ratios of 1.35 and 0.69, respectively. The stock has been observing a declining pattern with a recorded 1-year low at $0.38 and a high at $2.20, offering insights into market volatility and shifting investor sentiment.

TerrAscend Corp. is engaged in the cultivation, processing, and distribution of medical and adult-use cannabis products across Canada and the United States. The company is diversified across various product lines, including hemp-derived wellness products, as well as vapes, concentrates, topicals, tinctures, edibles, and operates retail dispensaries under the Apothecarium and State Flower brands. This diverse portfolio enables the company to cater to a broad spectrum of consumer needs within the wellness sector.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.


Sponsored Articles


Investing Ideas

Previous Next